Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics

Clinical and Experimental Allergy

Volumn 42, Issue 5, 2012, Pages 775-781

  Matsunaga, K ^a,b   Yanagisawa, S ^a   Hirano, T ^a   Ichikawa, T ^a   Koarai, A ^a   Akamatsu, K ^a   Sugiura, H ^a   Minakata, Y ^a   Kawayama, T ^b   Ichinose, M ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Airflow obstruction; Airway lability; Allergic rhinitis; Chronic rhinosinusitis; Eosinophil; Gastro esophageal reflux disease; Immunoglobulin E; Inhaled corticosteroids; Smoking

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; ATOPY; COMORBIDITY; DEMOGRAPHY; EOSINOPHIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RHINOSINUSITIS; SMOKING;

ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DEMOGRAPHY; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RISK FACTORS;

EID: 84859979218     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03945.x     Document Type: Article

References (37)

1. Barnes PJ, Pederson S, Busse WW Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157:S1-53.
2. Saleh D, Ernst P, Lim S, Banes PJ, Giaid A Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12:929-37.
3. Alving K, Weitzberg E, Lundberg JM Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-70.
4. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-5.
5. Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006; 130:1319-25.
6. Barnes PJ, Adock IM Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373:1905-17.
7. Scott M, Raza A, Karmaus W et al. Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax 2010; 65:258-62.
8. Matsunaga K, Hirano T, Akamatsu K et al. Exhaled nitric oxide cut-off values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects. Allergol Int 2011; 60:331-7.
9. Michils A, Louis R, Peche R, Baldassarre S, Muylem V Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J 2009; 33:1295-301.
10. Papainoannou AI, Minas M, Tanou K, Gourgoulianis KI, Kostikas K Exhaled NO may predict loss of asthma control: the effect of concomitant allergic rhinitis. Eur Respir J 2009; 34:1005-7.
11. Szefler SJ, Martin RJ Lessons learned from variation in response to therapy in clinical trials. J Allergy Clin Immunol 2010; 125:285-92.
12. Dweik RA, Sorkness RL, Whenzel S et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010; 181:1033-41.
13. Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006; 129:1492-9.
14. Michils A, Baldassarre S, Van Muylem A Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 2008; 31:539-46.
15. van Veen IH, Ten Brinke A, Sterk PJ et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J 2008; 32:344-9.
16. Mahut B, Peiffer C, Thibaudon M et al. What does a single exhaled nitric oxide measurement tell us in asthmatic children? J Asthma 2009; 46:810-4.
17. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-73.
18. Matsunaga K, Hirano T, Kawayama T et al. Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 2010; 59:363-7.
19. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63 (Suppl 86):8-160.
20. American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflex disease. Am J Gastroenterol 2005; 100:190-200.
21. Global initiative for asthma. Global strategy for asthma management and prevention: NHLBI/WHO Workshop report. NHLBI 2006.
22. Nathan RA, Sorkness CA, Kosinski M et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59-65.
23. Dweik RA, Boggs PB, Erzurum SC et al. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184:602-15.
24. Pijnenburg MWH, Bakker EM, Lever S, Hop WC, De Jongste JC High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Clin Exp Allergy 2005; 35:920-5.
25. Silkoff PE, Lent AM, Busacker AA et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005; 116:1249-55.
26. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic refractory asthma. European Network for Understanding Mechanisms of Refractory Asthma. Eur Respir J 2003; 22:470-7.
27. Sugiura H, Komaki Y, Koarai A, Ichinose M Nitrative stress in refractory asthma. J Allergy Clin Immunol 2008; 121:355-60.
28. Perez-de-Llano LA, Carballada F, Castro Anon O et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J 2010; 35:1221-7.
29. Little SA, Chalmers GW, MacLeod KJ, McSharry C, Thomson NC Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000; 55:232-4.
30. Strunk RC, Szefler SJ, Phillips BR et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112:883-92.
31. del Pozo V, de Arruda-Chaves E, de Anders B et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997; 158:859-67.
32. Thomazzi SM, Ferreira HH, Conran N, de Nucci G, Antunes E Role of nitric oxide on in vitro human eosinophill migration. Biochem Pharmacol 2001; 62:1417-21.
33. Ribeiro de Andrade C, Chatkin JM, Fiterman J, Scaglia N, Camargos PA Unified disease, unified management: treating allergic rhinitis and asthma with nasally inhaled corticosteroid. Respir Med 2010; 104:1577-80.
34. ten Brinke A, Grootendorst DC, Schmidt JT et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002; 109:621-6.
35. Rolla G, Colagrande P, Scappaticci E et al. Damage of the pharyngeal mucosa and hyperresponsiveness of airway in sinusitis. J Allergy Clin Immunol 1997; 100:52-7.
36. Guida G, Rolla G, Badiu I et al. Determintants of exhaled nitric oxide in chronic rhinosinusitis. Chest 2010; 137:658-64.
37. Chaundhri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308-11.